Current Developments in the Understanding of Mental Retardation Part II: Psychopathology

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 30, Issue 6, 1991, Pages 861-872

  BREGMAN, JOEL D ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

mental retardation; psychopathology

Indexed keywords

ARTICLE; BIOLOGY; HUMAN; MENTAL DEFICIENCY; MENTAL DISEASE; REVIEW; RISK FACTOR;

ADOLESCENT; AFFECTIVE SYMPTOMS; ATTENTION; CHILD; CHILD BEHAVIOR DISORDERS; HUMAN; MENTAL RETARDATION; MOTOR ACTIVITY; PSYCHOPATHOLOGY; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; THINKING;

EID: 0025724978     PISSN: 08908567     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004583-199111000-00001     Document Type: Article

References (113)

1. Stimulant drug effects in developmental disorders and hyperactivity—toward a resolution of disparate findings
2. Thioridazine dose effects with reference to stereotypic behavior in mentally retarded residents
3. Chlorpromazine effects on stereotypic and conditioned behaviour of severely retarded patients—a pilot study
4. Preliminary study of imipramine in profoundly retarded residents
5. The aberrant behavior checklist: factor structure and the effect of subject variables in American and New Zealand facilities
6. Haloperidol treatment with chronically medicated residents: dose effects on clinical behavior and contingencies
7. Control of aggressive and self-mutilative behavior in a mentally retarded patient with lithium
8. Haloperidol in the treatment of infantile autism: effects on learning and behavioral symptoms
9. The effects of haloperidol on discrimination learning and behavioral symptoms in autistic children
10. Brief report: effects of fenfluramine on behavioral, cognitive, and affective disturbances in autistic children
11. Reduction of stereotypic behaviours using differential reinforcement procedures and momentary restraint
12. Use of depression rating instruments in developmentally and educationally delayed adolescents
13. The dexamethasone suppression test in depressed adults: preliminary findings
14. Fragile-X syndrome: variability of phenotypic expression
15. Fragile-X syndrome: genetic predisposition to psychopathology
16. Fragile X and autism
17. A comparison of haloperidol, behavior therapy, and their interaction in autistic children
18. The effects of haloperidol on learning and behavior in autistic children
19. Tardive and withdrawal dyskinesia in autistic children: a prospective study
20. Efficacy of fenfluramine in autistic children
21. Naltrexone in autistic children: a double-blind and placebo-controlled study
22. Adults with Prader-Willi syndrome: abnormalities of sleep and behaviour
23. Psychiatric disturbance in mentally handicapped patients
24. Lithium in the treatment of aggression in mentally handicapped patients: a double-blind trial
25. Psychotropic drug treatment among learning-disabled, educable mentally retarded, and seriously emotionally disturbed students
26. Psychiatric disorders in the mentally retarded: types, problems, and challenges
27. Lithium treatment and cognitive changes in two mentally retarded patients
28. A single-subject study of imipramine in a mentally retarded woman with depressive symptoms
29. Neurological findings in patients with the fragile-X syndrome
30. The psychological profile of the fragile X syndrome
31. Affective disorders in mentally retarded adolescents—report of two cases with lithium treatment
32. Prevalence and efficacy of stimulant drug use with mentally retarded children and youth
33. Behaviour problems in retarded children with special reference to Down's syndrome
34. Psychiatric disorders in mildly and severely mentally retarded urban children and adolescents: epidemiological aspects
35. Rapid cycling affective disorders in the mentally retarded
36. A review of treatment research for self-injurious and stereotyped responding
37. Psychiatric illness among the mentally retarded. A Swedish population study
38. An analysis of autism in fifty males with the fragile-X syndrome
39. Double-blind assessment of Mellaril in a mentally retarded population using detailed evaluations
40. Naltrexone decreases self-injurious behavior
41. Individual psychotherapy with mentally retarded individuals: a review and call for research
42. Prevalence of psychopathology among mentally retarded adults
43. Problem behavior and psychiatric impairment within a developmentally disabled population I: behavior frequency
44. Problem behavior and psychiatric impairment within a developmentally disabled population III: psychotropic medication
45. Naltrexone attenuates self-injurious behavior in mentally retarded subjects
46. Brief report: clinical effects of fenfluramine in ten autistic subjects
47. Behavior disturbance in childhood and the early adult years in populations who were and were not mentally retarded
48. Behavior disturbance since childhood among a 5-year birth cohort of all mentally retarded young adults in a city
49. Developmental and behavioral disturbances in 13 boys with fragile-X syndrome
50. Effects of naltrexone on infantile autism
51. Decelerative treatment practices with persons who have mental retardation: a review of five years of the literature
52. Short-cycle manic-depressive psychosis in a mentally handicapped child without family history
53. The presence of psychiatric morbidity in mentally retarded adults
54. Psychiatric aspects of Down's syndrome
55. Bipolar disorder in mentally retarded adolescents
56. Effective behavioral treatment of self-biting by a child with Lesch-Nyhan syndrome
57. Relaxation reduces disruption in mentally handicapped adults
58. Assessment and treatment of clinical phobias in mentally retarded children
59. A review of treatment research for aggressive and disruptive behavior in the mentally retarded
60. Depression in mentally retarded children
61. A 20-year review of punishment and alternative methods to treat problem behaviors in developmentally delayed persons
62. Medication and treatment of schizophrenia in persons with mental retardation
63. Low-dose haloperidol for stereotypic self-injurious behavior in the mentally retarded. (letter)
64. The effects of intermittent drug therapy on stereotypy and collateral behaviors of mentally retarded persons
65. Psychopathology in hospitalized developmentally disabled individuals
66. Psychodynamics of the mildly retarded and borderline intelligence adult
67. Endogenous opioids and social behavior
68. Treatment of ADDH in mentally retarded children: a preliminary study
69. Desensitization for the treatment of fear in the high level adult retardate
70. Psychopathology and mental retardation: a study of 100 mentally retarded children: I. Psychopathology
71. Use of the dexamethasone suppression test to detect depressive disorders of mentally retarded individuals
72. Self-reports of depression by community-based mildly mentally retarded adults
73. Beta-blockers in the severely and profoundly mentally retarded
74. Brief report: open trial effects of beta-blockers on speech and social behaviors in 8 autistic adults
75. Buspirone therapy for maladaptive behavior and anxiety in developmentally disabled persons
76. Psychoses in adult mental defectives: II. Schizophrenic and paranoid psychoses
77. Psychiatric disorders in mentally handicapped children: a clinical and follow-up study
78. Schizophrenia in mental retardation: clinical features
79. Personality disorder in mental handicap
80. A double-blind, placebo controlled, crossover trial of carbamazepine in overactive, severely, mentally handicapped patients
81. Effects of fenfluramine on social behavior in autistic children
82. Psychosocial correlates of depression in mentally retarded adults: I. Minimal social support and stigmatization
83. The prevalence of tardive dyskinesia in a mentally retarded population
84. Effects of fenfluramine on 14 outpatients with the syndrome of autism
85. Study of fenfluramine in outpatients with the syndrome of autism
86. Diagnosis and lithium treatment of affective disorder in the retarded: five case studies
87. Social skills training with mentally handicapped people: a review
88. Psychological sequelae of brain damage in children
89. A neuropsychiatric study in childhood
90. Prevalence of self-injurious behaviors in a large state facility for the retarded: a three-year follow-up study
91. Fenfluramine: Neurotoxicity
92. An inventory to assess psychopathology of mentally retarded adults
93. Individual and group psychotherapy with mentally retarded adolescents
94. Adaptive behavior of institutionalized individuals with Down syndrome
95. The use of valproate in the treatment of mentally retarded persons with typical and atypical bipolar disorders
96. The management of chronic behavior disorders in mentally retarded adults with lithium carbonate
97. Lithium carbonate for aggression in mentally retarded persons
98. Psychotherapies with the mentally retarded
99. Lithium responsive manic-like symptoms in two individuals with autism and mental retardation
100. Effects of fenfluramine on eight outpatients with the syndrome of autism
101. Naltrexone in treatment of self injurious behavior: a clinical study
102. Schizophrenia and mental handicap: an historical review, with implications for further research
103. Factors associated with a good response to lithium in aggressive mentally handicapped subjects
104. Obsessive-compulsive disorder in mentally retarded patients
105. A case report of naltrexone treatment of self-injury and social withdrawal in autism
106. Emotional symptoms in Prader-Willi syndrome adolescents
107. The effects of propranolol on uncontrolled rage outbursts in children and adolescents with organic brain dysfunction
108. The presentation of mental illness in mentally retarded adults
109. Personality development and the dually diagnosed person